Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Enveric Biosciences, Inc. issued up to 328,802 shares of Common Stock of warrant to certain institutional investors for exercise price of $4.16 per share.
- Security
- warrant
- Shares
- up to 328,802 shares of Common Stock
- Purchaser
- certain institutional investors
- Consideration
- exercise price of $4.16 per share
Exact text from the filing
up to 328,802 shares of Common Stock (the “Series H Warrants”, and collectively with the Series G Warrants, the “Common Warrants”). The Common Warrants have an exercise price of $4.16 per share (subject to customary adjustments as set forth in the Common Warrants) and are exercisable immediately. The Series G Warrants will expire five (5) following the
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Enveric Biosciences, Inc. issued 328,802 shares of common stock to certain institutional investors for $4.41 per share.
- Security
- common stock
- Shares
- 328,802 shares
- Purchaser
- certain institutional investors
- Consideration
- $4.41 per share
Exact text from the filing
the Company agreed to issue and sell to the Investors in a registered direct offering, an aggregate of 328,802 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a price of $4.41 per share
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Enveric Biosciences, Inc. issued up to 23,016 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC (Placement Agent) for exercise price equal to $5.5125 per share.
- Security
- warrant
- Shares
- up to 23,016 shares of Common Stock
- Purchaser
- H.C. Wainwright & Co., LLC (Placement Agent)
- Consideration
- exercise price equal to $5.5125 per share
Exact text from the filing
Agent Warrants”) to purchase up to 23,016 shares of Common Stock to the Placement Agent (including its designees). The Placement Agent Warrants have an exercise price equal to $5.5125 per share and are exercisable for five (5) years from the commencement of sales in the Offerings. The Common Warrants and Placement Agent Warrants and the shares of our Common
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Enveric Biosciences, Inc. entered into Purchase Agreement with certain institutional investors valued at approximately $1.5 million (effective 2026-01-27).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- certain institutional investors
- Value
- approximately $1.5 million
- Effective
- 2026-01-27
Exact text from the filing
On January 27, 2026, Enveric Biosciences, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors (each, an “Investor”)
View on SEC.gov